Fortress Biotech Inc

FBIOP

Company Profile

  • Business description

    Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

  • Contact

    1111 Kane Concourse
    Suite 301
    Bay Harbor IslandFL33154
    USA

    T: +1 781 652-4500

    E: [email protected]

    https://www.fortressbiotech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    Employees

    101

Stocks News & Analysis

stocks

Nvidia: Collaboration with Intel might bring some goodwill with the US

We doubt the $5 billion is meaningful enough to force Nvidia to use Intel, either for core products or even for the chips in collaboration.
stocks

What now for Santos after takeover offer collapses?

Our Fair Value estimate once again reflects the stand-alone business and its growth potential.
stocks

Morningstar initiates coverage on small cap ASX REIT

Coverage of ASX listed REIT as investor interest in property continues to grow.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,061.2061.30-0.67%
CAC 407,929.3174.700.95%
DAX 4023,778.97104.440.44%
Dow JONES (US)46,142.42124.100.27%
FTSE 1009,236.558.440.09%
HKSE26,545.10106.590.40%
NASDAQ22,470.72209.400.94%
Nikkei 22545,045.81143.540.32%
NZX 50 Index13,231.663.23-0.02%
S&P 5006,631.9631.610.48%
S&P/ASX 2008,773.5075.00-0.85%
SSE Composite Index3,820.0911.57-0.30%

Market Movers